ConductScience.org, home

Paper36768533

Biomarkers of Aggressive Prostate Cancer at Diagnosis.

Boehm BE and 4 others. Int J Mol Sci, 2023. Cited by 61 papers, by iCite.

Cite this record

ConductScience Library. Biomarkers of Aggressive Prostate Cancer at Diagnosis. Papers, record 36768533. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36768533

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Biomarkers of Aggressive Prostate Cancer at Diagnosis.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
61
iCite
Relative citation ratio, by iCite
6.42
iCite
Revised in PubMed
2024-09-12
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Boehm BEBrock E
2York MEMonica Ehttps://orcid.org/0000-0003-3350-9244
3Petrovics GGyorgy
4Kohaar IIndu
5Chesnut GTGregory T

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Prostatic NeoplasmsMajor topic
Male
Humans
United States
Prostate
Prostate-Specific Antigen
Early Detection of Cancer
Biopsy
Biomarkers, Tumor

Source PubMed

Download CSV of topics

References115

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125454615A multi-institutional prospective trial in the USA confirms that the 4Kscore accurately identifies men with high-grade prostate cancer.Eur Urol2015https://conductscience.org/library/papers/25454615PubMed
228111174A Systematic Review and Meta-analysis of the Diagnostic Accuracy of Prostate Health Index and 4-Kallikrein Panel Score in Predicting Overall and High-grade Prostate Cancer.Clin Genitourin Cancer2017https://conductscience.org/library/papers/28111174PubMed
332901135Cancer health disparities in racial/ethnic minorities in the United States.Br J Cancer2021https://conductscience.org/library/papers/32901135PubMed
435040965Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.JAMA Netw Open2022https://conductscience.org/library/papers/35040965PubMed
527108162Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score.Eur Urol2016https://conductscience.org/library/papers/27108162PubMed
622999998Clinical utility of an epigenetic assay to detect occult prostate cancer in histopathologically negative biopsies: results of the MATLOC study.J Urol2013https://conductscience.org/library/papers/22999998PubMed
729660369Evaluation of an Epigenetic Assay for Predicting Repeat Prostate Biopsy Outcome in African American Men.Urology2019https://conductscience.org/library/papers/29660369PubMed
832382078Clinical utility of the exosome based ExoDx Prostate(IntelliScore) EPI test in men presenting for initial Biopsy with a PSA 2-10 ng/mL.Prostate Cancer Prostatic Dis2020https://conductscience.org/library/papers/32382078PubMed
925636659Multicenter Evaluation of the Prostate Health Index to Detect Aggressive Prostate Cancer in Biopsy Naïve Men.J Urol2015https://conductscience.org/library/papers/25636659PubMed
1018295257PCA3: a molecular urine assay for predicting prostate biopsy outcome.J Urol2008https://conductscience.org/library/papers/18295257PubMed
1131629423African American and Asian males: what do we know about germline predisposition to prostate cancer.Can J Urol2019https://conductscience.org/library/papers/31629423PubMed
1223201468Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer.Eur Urol2014https://conductscience.org/library/papers/23201468PubMed
1335292633Germline mutation landscape of DNA damage repair genes in African Americans with prostate cancer highlights potentially targetable RAD genes.Nat Commun2022https://conductscience.org/library/papers/35292633PubMed
1423861782Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) significantly improve prostate cancer detection at initial biopsy in a total PSA range of 2-10 ng/ml.PLoS One2013https://conductscience.org/library/papers/23861782PubMed
1526443432Racial Variations in Prostate Cancer Molecular Subtypes and Androgen Receptor Signaling Reflect Anatomic Tumor Location.Eur Urol2016https://conductscience.org/library/papers/26443432PubMed
1633792737MRI index lesion radiomics and machine learning for detection of extraprostatic extension of disease: a multicenter study.Eur Radiol2021https://conductscience.org/library/papers/33792737PubMed
1719297565Mortality results from a randomized prostate-cancer screening trial.N Engl J Med2009https://conductscience.org/library/papers/19297565PubMed
1827032035A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy.JAMA Oncol2016https://conductscience.org/library/papers/27032035PubMed
1933080150Use of the MyProstateScore Test to Rule Out Clinically Significant Cancer: Validation of a Straightforward Clinical Testing Approach.J Urol2021https://conductscience.org/library/papers/33080150PubMed
2034083737Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differences.Commun Biol2021https://conductscience.org/library/papers/34083737PubMed

See all 115 referencesDownload CSV of references

Cited by44

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 61 citations.

PMIDTitleJournalYearIn PapersSource
42958227Integration of bulk RNA-seq data with single-cell RNA-seq data to identify urinary biomarkers derived from prostate tumor tissues.BMC Urol2026https://conductscience.org/library/papers/42958227PubMed
42638975IL27 expression and IL27RA-dependent cellular responses are associated with biochemical recurrence and immune-regulatory features in prostate cancer.Front Immunol2026https://conductscience.org/library/papers/42638975PubMed
42484820An Integrated Cell-Death Program Defines Aggressive Prostate Cancer by Coupling Ezrin to the Hippo-YAP/TAZ Axis.Ann Surg Oncol2026https://conductscience.org/library/papers/42484820PubMed
42195404Olfactory Science and Technology in Prostate Cancer Diagnosis: From Invertebrate Models to Artificial Intelligence.Life (Basel)2026https://conductscience.org/library/papers/42195404PubMed
42153014Kombucha tea in cancer care: A review of its anti-cancer potential and role in integrative oncology.Avicenna J Phytomed2026https://conductscience.org/library/papers/42153014PubMed
42074564Non-Coding RNAs in Cancer: Decoding Regulatory Networks for Liquid Biopsy Applications.Genes (Basel)2026https://conductscience.org/library/papers/42074564PubMed
42072359Integrative Whole-Genome and Epigenome Profiling of cfDNA in Familial Prostate Cancer: Insights from a Pilot Study.Biomedicines2026https://conductscience.org/library/papers/42072359PubMed
41970982Development and validation of a clinical nomogram based on lasso-logistic regression for predicting prostate cancer with PSA 4-20.0 ng/mL: a retrospective study.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/41970982PubMed
41762538From prostate specific antigen to genomic signatures: Advances in biomarkers for prostate cancer diagnosis and prognosis.Transl Oncol2026https://conductscience.org/library/papers/41762538PubMed
41607771Editorial: Streamlining drug approvals: addressing policy challenges in genitourinary oncology.Front Immunol2025https://conductscience.org/library/papers/41607771PubMed
41395283Diagnostic utility of serum prostate-specific antigen and circulating inflammatory markers for differentiating prostate cancer from benign prostatic hyperplasia.Am J Cancer Res2025https://conductscience.org/library/papers/41395283PubMed
41374944The Clinical Relevance of Tumor Biomarkers in Prostate Cancer-A Review.Cancers (Basel)2025https://conductscience.org/library/papers/41374944PubMed
41254603Prostate cancer misdiagnosed as prostatic abscess: case report and literature review.BMC Urol2025https://conductscience.org/library/papers/41254603PubMed
41050870Integrating Proteomic Analysis and Machine Learning to Predict Prostate Cancer Aggressiveness.Stats (Basel)2024https://conductscience.org/library/papers/41050870PubMed
40862934Shining the Path of Precision Diagnostic: Advancements in Photonic Sensors for Liquid Biopsy.Biosensors (Basel)2025https://conductscience.org/library/papers/40862934PubMed
40861808A Promising Prognostic Signature Consisting of Fatty Acid Metabolism Genes based on Machine Learning Predicts Biochemical Recurrence and Aids ARSI Therapy in Prostate Cancer.J Cancer2025https://conductscience.org/library/papers/40861808PubMed
40849720METCAM/MUC18 is a Biomarker and Therapeutic Target for Prostate Cancer.Asian Pac J Cancer Prev2025https://conductscience.org/library/papers/40849720PubMed
40673839Roadblocks of Urinary EV Biomarkers: Moving Toward the Clinic.J Extracell Vesicles2025https://conductscience.org/library/papers/40673839PubMed
40606769Blood and urine-based biomarkers in prostate cancer: Current advances, clinical applications, and future directions.J Liq Biopsy2025https://conductscience.org/library/papers/40606769PubMed
40445561Advance in prostate cancer biomarker discovery: bridging detection, prognosis and therapeutics.Discov Oncol2025https://conductscience.org/library/papers/40445561PubMed

See all 44 cited byDownload CSV of cited by

Genes15

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36768533

GET https://conductscience.org/api/papers/v1/36768533/references?page=2